Delivery Order SPE2DB22D1106-SPE2DB25FFHQ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,625.40 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be performed at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Promethegan 12.5 mg suppositories (12-count units) with a ceiling value of $1,950.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count packages) valued at $1,383.72 with a completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a $7,329.92 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,794.40 firm fixed price delivery order to provide PROMETHEGAN 25 MG SUPPOSITORY 12S pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.03 firm fixed-price delivery order is for the supply of PROMETHEGAN 25 MG SUPPOSITORY 12S medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.75, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of December 4, 2023, and is a firm fixed-price type with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHQ3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promethegan 25 mg suppositories in quantities of 12 units. The order, valued at $2,577.42 with a firm fixed price structure, represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp fulfills critical medical supply needs for the Department of Defense and federal healthcare systems through its prime vendor contract, which enables the company to supply medications, vaccines, and medical commodities across multiple therapeutic domains in support of military healthcare programs worldwide. The company's extensive contract portfolio with DLA demonstrates its capability to meet federal procurement requirements through open competition, serving various customers including the Defense Health Agency and U.S. Coast Guard. The award of this delivery order for Promethegan reflects the company's ongoing role in supporting military medical readiness through reliable pharmaceutical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/9/25 |